ZMYND19-ARRDC1 Fusion FISH Probe
The ZMYND19-ARRDC1 Fusion FISH Probe is used to confirm a fusion of the ZMYND19 and ARRDC1 genes. The fusion of the ZMYND19 and ARRDC1 genes has been associated with Thyroid Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ZMYND19-ARRDC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ZMYND19-ARRDC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
ARRDC1 Gene Summary
The Arrestin Domain Containing 1 (ARRDC1) gene is located on chr9 :140500095-140509812 at 9q34.3.
Gene Name: Arrestin Domain Containing 1
Chromosome: CHR9: 140500095 -140509812
Locus: 9q34.3
ZMYND19 Gene Summary
ZMYND19 is a MYND zinc finger domain-containing protein that binds to the C terminus of melanin-concentrating hormone receptor-1 (MCHR1; MIM 601751) (Bachner et al., 2002 [PubMed 12208518]), and to the N termini of alpha-tubulin (TUBA1; MIM 191110), and beta-tubulin (TUBB; MIM 191130) (Francke et al., 2005 [PubMed 16039987]).[supplied by OMIM, Mar 2008]
Gene Name: Zinc Finger MYND-type Containing 19
Chromosome: CHR9: 140476530 -140484937
Locus: 9q34.3
Gene Diseases
The ZMYND19 ARRDC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Thyroid Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|